Prostate Cancer - Results from #25160

Small prostate size and high grade disease-biology or artifact? - Abstract May 3, 2011

Inhibition of prostate cancer using RNA interference-directed knockdown of platelet-derived growth factor receptor - Abstract May 3, 2011

A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer - Abstract May 3, 2011

Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer - Abstract May 3, 2011

Pelvic nodal radiotherapy in patients with unfavorable intermediate and high-risk prostate cancer: Evidence, rationale, and future directions - Abstract May 3, 2011

Computer-aided analysis of transrectal ultrasound images of the prostate - Abstract May 3, 2011

Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: Results of a prospective study in a clinical setting - Abstra May 3, 2011

Pathological findings after radical prostatectomy in men eligible for active surveillance (French trial SURACAP): Is the misclassification rate acceptable? - Abstract May 3, 2011

Editor's Commentary - Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study May 3, 2011

EAU 2011 - Open radical prostatectomy (ORP) performed by low volume surgeons predisposes to higher rates of venous thrombosis (VT) and pulmonary embolism (PE) - Session Highlights May 3, 2011

EAU 2011 - Influence of high dose low molecular weight heparin (LMWH) on blood transfusion and lymphocele rate in open radical prostatectomy - Session Highlights May 3, 2011

EAU 2011 - Combining screening and chemoprevention of prostate cancer - Session Highlights May 3, 2011

EAU 2011 - Results from the Gothenburg randomized prostate cancer screening trial - Session Highlights May 3, 2011

The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers - Abstract May 2, 2011

Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy - Abstract May 2, 2011

Avoiding androgen deprivation therapy in men with high-risk prostate cancer: The role of radical prostatectomy as initial treatment - Abstract May 2, 2011

Prostate cancer treatment ascertained from several sources: Analysis of disagreement and error - Abstract May 2, 2011

Factors associated with downgrading in patients with high grade prostate cancer - Abstract May 2, 2011

A longitudinal study of changes in provider-patient interaction in treatment of localized prostate cancer - Abstract May 2, 2011

Comorbidity and competing risks for mortality in men with prostate cancer - Abstract May 2, 2011

Page 1259 of 1289